ANAPHYLAXIS TO PANTOPRAZOLE AND OMEPRAZOLE WITH CROSS-REACTIVITY TO ALL PROTON PUMP INHIBITORS: IDENTIFICATION OF A SAFE ALTERNATIVE

Öz

Proton pump inhibitors (PPIs) are widely prescribed for the management of peptic diseases, including gastroesophageal reflux (GER) and gastric ulcers. The risk profile of PPIs is acceptable, and hypersensitivity reactions to PPIs are extremely rare. We present a case in which type I hypersensitivity reactions to all PPIs were confirmed. A 43-year-old woman was admitted to our inpatient clinic with a history of anaphylactic reactions to both pantoprazole and omeprazole. Allergy work-up revealed an IgE-mediated hypersensitivity to all proton pump inhibitors. H2 receptor antagonist famotidine was considered safe after negative results on both the skin prick test (SPT) and oral provocation test (OPT) .

Anahtar Kelimeler

• Proton pump inhibitors
• Anaphylaxis
• Hypersensitivity reaction
• Skin prick tests

Kaynakça

1. Bonadonna P, Lombardo C, Bortolami O, Bircher A, Scherer K, Barbaud A, et al. Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test. J Allergy Clin Immunol 2012;130(2):547-9. google scholar
2. Ward RM, Kearns GL. Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs 2013;15(2):119-31. google scholar
3. Thomson AB, Sauve MD, Kassam N, Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 2010;16(19):2323-30. google scholar
4. Strand DS, Kim D, Peura DA. 25 Years of proton pump inhibitors: A comprehensive review. Gut Liver 2017;11(1):27-37. google scholar
5. Kepil Özdemir S, Yılmaz I, Aydin Ö, Büyüköztürk S, Gelincik A, Demirtürk M, et al. Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity. Allergy 2013;68(8):1008-14. google scholar
6. Kepil Özdemir S, Öner Erkekol F, Ünal D, Büyüköztürk S, Gelincik A, Dursun AB, et al. Management of hypersensitivity reactions to proton pump inhibitors: A retrospective experience. Int Arch Allergy Immunol 2016;171(1):54-60. google scholar
7. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57(1):45-51. google scholar
8. Bavbek S, Kepil Özdemir S, Bonadonna P, Atanaskovic-Markovic M, Barbaud A, Brockow K, et al. Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper. Allergy. 2024;79(3):552-64. google scholar

9. Bose S, Guyer A, Long A, Banerji A. Evaluation and management of hypersensitivity to proton pump inhibitors. Ann Allergy Asthma Immunol 2013;111(6):452-7. google scholar
10. Lobera T, Navarro B, Del Pozo MD, González I, Blasco A, Escudero R, et al. Nine cases of omeprazole allergy: Cross-reactivity between proton pump inhibitors. J Investig Allergol Clin Immunol 2009;19(1):57-60. google scholar
11. Elfau MS, Sotillos MG, Clavería LF, Arazuri NS, Ballarin SM, Sanz CC. Study of cross-reactivity between proton pump inhibitors. J Investig Allergol Clin Immunol 2010;20(2):157-61. google scholar
12. Turedi O, Sozener ZC, Kendirlinan R, Bavbek S. A case of pantoprazole anaphylaxis with cross reactivity to all proton pump inhibitors: Finding a safe alternative. Curr Drug Saf 2017;12(3):198-200. google scholar
13. Scarpignato C, Hunt RH. Potassium-competitive acid blockers: Current clinical use and future developments. Curr Gastroenterol Rep 2024;26(11):273-93. google scholar
14. Laine L, DeVault K, Katz P, Mitev S, Lowe J, Hunt B, et al. Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial. Gastroenterology. 2023;164(1):61-71. google scholar